ALLIENT INC (ALNT) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.61%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.61% | Share-based compensation / revenue. Period ending 2026-06-30. $3.52M ÷ $574.78M × 100 ≈ 0.61% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 574.78M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 3.52M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 48.46M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $574.78M | $3.52M | $48.46M | (m) | (m) | 0.61% | (m) | (m) |
| 2026-03-31 | (m) | $560.59M | $3.36M | $44.53M | (m) | (m) | 0.60% | (m) | (m) |
| 2025-12-31 | (m) | $554.48M | $3.43M | $43.98M | (m) | (m) | 0.62% | (m) | (m) |
| 2025-09-30 | (m) | $533.13M | $3.35M | $39.08M | (m) | (m) | 0.63% | (m) | (m) |
| 2025-06-30 | (m) | $519.60M | $3.62M | $33.52M | (m) | (m) | 0.70% | (m) | (m) |
| 2025-03-31 | (m) | $516.06M | $3.86M | $26.72M | (m) | (m) | 0.75% | (m) | (m) |
| 2024-12-31 | (m) | $529.97M | $4.15M | $30.04M | (m) | (m) | 0.78% | (m) | (m) |
| 2024-09-30 | (m) | $548.96M | $4.69M | $30.64M | (m) | (m) | 0.86% | (m) | (m) |
| 2024-06-30 | (m) | $569.06M | $4.95M | $35.88M | (m) | (m) | 0.87% | (m) | (m) |
| 2024-03-31 | (m) | $579.80M | $5.42M | $43.02M | $12.79M | (m) | 0.93% | 3.36× | Reported |
| 2023-12-31 | (m) | $578.63M | $5.48M | $42.31M | $12.38M | (m) | 0.95% | 3.42× | Reported |
| 2023-09-30 | (m) | $568.71M | $5.49M | $43.45M | $12.10M | (m) | 0.96% | 3.59× | Reported |
| 2023-06-30 | (m) | $557.80M | $5.39M | $43.28M | $11.27M | (m) | 0.97% | 3.84× | Reported |
| 2023-03-31 | (m) | $533.75M | $4.99M | $38.78M | $9.64M | (m) | 0.94% | 4.02× | Reported |
| 2022-12-31 | (m) | $502.99M | $5.07M | $31.66M | $7.69M | (m) | 1.01% | 4.12× | Reported |
| 2022-09-30 | (m) | $468.70M | $4.81M | $27.49M | $5.69M | (m) | 1.03% | 4.83× | Reported |
| 2022-06-30 | (m) | $437.81M | $4.85M | $24.46M | $4.13M | (m) | 1.11% | 5.92× | Reported |
| 2022-03-31 | (m) | $416.62M | $4.71M | $23.68M | $3.41M | (m) | 1.13% | 6.94× | Reported |
| 2021-12-31 | (m) | $403.52M | $4.16M | $26.03M | $3.24M | (m) | 1.03% | 8.04× | Reported |
| 2021-09-30 | (m) | $399.72M | (m) | $26.79M | $3.36M | (m) | (m) | 7.97× | Reported |
| 2021-06-30 | (m) | $390.87M | (m) | $24.57M | $3.43M | (m) | (m) | 7.17× | Reported |
| 2021-03-31 | (m) | $375.99M | (m) | $22.89M | $3.52M | (m) | (m) | 6.50× | Reported |
| 2020-12-31 | (m) | $366.69M | (m) | $22.99M | $3.72M | (m) | (m) | 6.19× | Reported |
| 2020-09-30 | (m) | $361.62M | (m) | $23.92M | $3.96M | (m) | (m) | 6.04× | Reported |
| 2020-06-30 | (m) | $363.60M | (m) | $26.27M | $4.47M | (m) | (m) | 5.87× | Reported |
| 2020-03-31 | (m) | $369.57M | (m) | $28.83M | $5.01M | (m) | (m) | 5.76× | Reported |
| 2019-12-31 | (m) | $371.08M | (m) | $29.44M | $5.13M | (m) | (m) | 5.73× | Reported |
| 2019-09-30 | (m) | $357.12M | (m) | $27.11M | $4.84M | (m) | (m) | 5.61× | Reported |
| 2019-06-30 | (m) | $340.58M | (m) | $25.52M | $4.10M | (m) | (m) | 6.22× | Reported |
| 2019-03-31 | (m) | $327.93M | (m) | $24.14M | $3.27M | (m) | (m) | 7.39× | Reported |
| 2018-12-31 | (m) | $310.61M | (m) | $23.23M | $2.70M | (m) | (m) | 8.60× | Reported |
| 2018-09-30 | (m) | (m) | (m) | $25.05M | $2.52M | (m) | (m) | 9.96× | Reported |
| 2018-06-30 | (m) | (m) | (m) | $23.09M | $2.53M | (m) | (m) | 9.14× | Reported |
| 2018-03-31 | (m) | (m) | (m) | $20.85M | $2.56M | (m) | (m) | 8.13× | Reported |
| 2017-12-31 | (m) | (m) | (m) | $18.80M | $2.47M | (m) | (m) | 7.60× | Reported |
| 2017-09-30 | (m) | (m) | (m) | $16.20M | $3.62M | (m) | (m) | 4.48× | Reported |
| 2017-06-30 | (m) | (m) | (m) | $16.26M | $4.49M | (m) | (m) | 3.62× | Reported |
| 2017-03-31 | (m) | (m) | (m) | $18.49M | $5.44M | (m) | (m) | 3.40× | Reported |
| 2016-12-31 | (m) | (m) | (m) | $18.88M | $6.45M | (m) | (m) | 2.93× | Reported |
| 2016-09-30 | (m) | (m) | (m) | $18.05M | $6.12M | (m) | (m) | 2.95× | Reported |
| 2016-06-30 | (m) | (m) | (m) | $20.06M | $6.12M | (m) | (m) | 3.28× | Reported |
| 2016-03-31 | (m) | (m) | (m) | $19.83M | $6.04M | (m) | (m) | 3.28× | Reported |
| 2015-12-31 | (m) | (m) | (m) | $20.93M | $6.02M | (m) | (m) | 3.48× | Reported |
| 2015-09-30 | (m) | (m) | (m) | $25.23M | $6.07M | (m) | (m) | 4.16× | Reported |
| 2015-06-30 | (m) | (m) | (m) | $25.46M | $6.17M | (m) | (m) | 4.12× | Reported |
| 2015-03-31 | (m) | (m) | (m) | $25.21M | $6.31M | (m) | (m) | 3.99× | Reported |
| 2014-12-31 | (m) | (m) | (m) | $24.15M | $6.43M | (m) | (m) | 3.75× | Reported |
| 2014-09-30 | (m) | (m) | (m) | $20.66M | $6.31M | (m) | (m) | 3.27× | Reported |
| 2014-06-30 | (m) | (m) | (m) | $14.59M | $4.71M | (m) | (m) | 3.10× | Reported |
| 2014-03-31 | (m) | (m) | (m) | $10.17M | $3.07M | (m) | (m) | 3.31× | Reported |
| 2013-12-31 | (m) | (m) | (m) | $7.06M | $1.45M | (m) | (m) | 4.88× | Reported |
| 2013-09-30 | (m) | (m) | (m) | $4.99M | $31.00K | (m) | (m) | 160.84× | Reported |
| 2013-06-30 | (m) | (m) | (m) | $5.83M | $20.00K | (m) | (m) | 291.30× | Reported |
| 2013-03-31 | (m) | (m) | (m) | $6.94M | $15.00K | (m) | (m) | 462.47× | Reported |
| 2012-12-31 | (m) | (m) | (m) | $7.13M | $13.00K | (m) | (m) | 548.31× | Reported |
| 2012-09-30 | (m) | (m) | (m) | $9.15M | $28.00K | (m) | (m) | 326.86× | Reported |
| 2012-06-30 | (m) | (m) | (m) | $9.51M | $47.00K | (m) | (m) | 202.36× | Reported |
| 2012-03-31 | (m) | (m) | (m) | $9.44M | $67.00K | (m) | (m) | 140.94× | Reported |
| 2011-12-31 | (m) | (m) | (m) | $9.65M | $84.00K | (m) | (m) | 114.90× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | $4.97M | $3.00K | (m) | (m) | 1657.33× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FREQUENCY ELECTRONICS INC (FEIM) | United States | $0.952B | 236.51 |
| COHU INC (COHU) | United States | $3.015B | -82.78 |
| TRANSCAT INC (TRNS) | United States | $0.805B | 250.33 |
| AEHR TEST SYSTEMS (AEHR) | United States | $3.176B | -420.65 |
| INTEST CORP (INTT) | United States | $0.146B | 291.94 |
| ScanTech AI Systems Inc. (STAI) | United States | $0.069B | -2.69 |
| DATA I/O CORP (DAIO) | United States | $0.030B | -4.65 |
| ITRON, INC. (ITRI) | United States | $4.008B | 13.83 |
| Veralto Corp (VLTO) | United States | $23.619B | 22.32 |
| TERADYNE, INC (TER) | United States | $60.595B | 59.25 |